The pharmaceutical industry is a complex ecosystem where the efficacy of final drug products hinges on the quality of every component, especially the chemical intermediates used in their synthesis. This article provides an overview of CAS 67915-31-5, a specific Piperazine derivative that plays a crucial role in this supply chain.

CAS 67915-31-5 refers to a particular Piperazine derivative, a fine chemical that is indispensable for various synthetic processes, most notably in the pharmaceutical sector. Typically supplied with a high purity of 99%, this compound is a testament to the advanced manufacturing capabilities available from suppliers, particularly those based in China. Its powder form and well-defined chemical structure make it a reliable starting material for complex synthesis pathways.

The journey of a pharmaceutical intermediate from production to use involves several critical considerations. For CAS 67915-31-5, these include ensuring consistent supply ability, understanding packaging requirements, and navigating international trade terms like FOB and CIF. Manufacturers committed to quality assurance, often certified by ISO standards, provide the assurance needed for pharmaceutical applications where precision and reliability are paramount.

The primary application for this Piperazine derivative lies in its role as a pharmaceutical intermediate, contributing to the synthesis of active pharmaceutical ingredients (APIs). Its chemical properties are leveraged in the development of various therapeutic agents, including those designed to combat fungal infections. This makes it a valuable asset for research institutions and pharmaceutical companies engaged in drug discovery and development.

For procurement professionals and R&D teams, identifying and partnering with dependable suppliers of CAS 67915-31-5 is a strategic imperative. A strong supplier relationship ensures not only the availability of the intermediate but also provides access to technical data, regulatory support, and competitive pricing. By understanding the nuances of sourcing such critical fine chemicals, companies can build more resilient and effective supply chains, ultimately contributing to the advancement of healthcare.